News & Events News Releases April 5, 2024 NGM Bio Announces Closing of Tender Offer Learn More → March 19, 2024 NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting Learn More → March 11, 2024 NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results Learn More → View All Events January 18, 2024 at 2:30 PM EST B. Riley Securities 4th Annual Oncology Conference Listen to webcast October 17, 2022 at 5:00 AM PDT CATALINA Topline Results Conference Call View Webcast June 29, 2022 from 11:00 AM to 12:30 PM EDT Explorer Series 4: NGM621 View Webcast Combined Shape View All